Adaptimmune Therapeutics plc

Q4 2016 13F Holders

Symbol
ADAP
CUSIP
00653A107
Type
Equity
Class
SPONDS ADR
Num filings
40
Total reported value, excl. options
$121 M
Manager Report Date Value ($000) Shares Option Type